They are only licensed for type 2 diabetes and obesity management
In one study, microdosing GLP-1s supported moderate weight loss of up to 10 pounds over 40 weeks in participants. MICRODOSING GLP-1 BENEFITS Do More, Age Less Modulated inflammatory pathways in clinical trials. Studies found a reduced risk of cognitive decline Supported cardiovascular health in clinical trials Improved mitochondrial function and oxidative stress in clinical trials Low doses reduced side effects in clinical trials Supported moderate weight loss of up to 10 pounds over 40 weeks in one study *See studies cited below
Key markers such as blood sugar levels, cholesterol, thyroid function, and overall health history are reviewed to ensure treatment safety and appropriateness
Case reports have documented instances where acetyl-L-carnitine supplementation triggered severe psychiatric symptoms in individuals with bipolar disorder
Statements Author contributions DeP: Hypotheses proposal, Literature search, Writing, Review, Editing
983-P: effect and safety of flexible dose adjustment with oral semaglutide vs